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Abstract
Purpose Oxygen therapy (hyperoxia) is essential for the treat-
ment of some neonatal critical care conditions. The lung is the
primary target for the changes induced by hyperoxia. Secre-
tory immunoglobulin A (SIgA), IgA and secretory component
(SC) reflect the local immunity in the respiratory tract induced
by hyperoxia.
Methods The enzyme-linked immunosorbent assay, immuno-
histochemistry staining, Western blot and Real-time PCR
were used to detect the levels of cytokines, IgA and SIgA in
bronchoalveolar lavage as well as IgA and SC/pIgR in pul-
monary tissue.
Results The levels of IgA and SIgA in BAL fluid were
gradually increased following neonatal rat development.
Compared with air-inhaling group, in the hyperoxia group
IgA, SIgA and other cytokines except IL-1 in BAL fluid were
significantly elevated on the 3rd, 5th and 7th days, but on the
10th day TNF-α, SIgA and IgA rapidly decreased. In the
hyperoxia group, both the protein expression of SC/pIgR
and the mRNA expression of SC/pIgR were remarkably in-
creased on the 3rd, 5th and 7th days, but were significantly
decreased on the 10th day, respectively. Conclusion: The large
amount of SIgA, IgA and SC in the early period of hyperoxia
might protect the lungs of the neonatal rats against acute
pulmonary injury, however, in the late period of hyperoxia,
the abruptly drop of SIgA and its component might lead to
pulmonary immunity abnormality. In hyperoxia, the increased
expression of cytokines might contribute to the expression of
IgA and SC.
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Introduction
Secretory immunoglobulin A (SIgA) is the major immuno-
globulin of the respiratory tract and other mucosal surfaces [1,
2]. It binds with bacteria and other pathogens to prevent their
adherence to mucosal cell surfaces and their subsequent sys-
temic invasion. SIgA is generally considered to be a non-
inflammatory antibody, since it only induces “immune exclu-
sion” and results in “immune balance” among mucosal tissues
[3–6]. SIgA level increases to protect against infection after
injury [7]. SIgA is composed of IgA, secretory component
(SC) and J chain. SC is the extracellular component of the
polymeric Ig receptor (pIgR) that is responsible for the
transcytosis of newly synthesized IgA (polymeric IgA, pIgA).
It is essential for defense against bacteria [8], parasites [9] and
for immunologically mediated neutralization of cholera toxin
[10]. SC also participates in innate protection against mucosal
pathogens [11]. So SIgA and SC play an important roles in
innate immunity in intestine, respiratory tract and other mu-
cosal sites.
Oxygen therapy (continuously inhaling a high concentra-
tion of oxygen, which results in hyperoxia) is essential for the
treatment of some neonatal critical care conditions. Since the
lungs are the primary targets of hyperoxia, pathophysiological
manifestations of pulmonary oxygen toxicity have been ex-
tensively studied in neonatal rats [12]. However, few studies
have reported changes in pulmonary immunity induced by
hyperoxia. Our previous studies had demonstrated that mod-
erate oxygen induced an increase and hyperoxia induced a
decrease of intestinal SC in vivo and in vitro [13] and that ileal
SIgAwas remarkably increased in neonatal rats under condi-
tions of hyperoxia [14]. In the present work, neonatal rats were
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under the hyperoxia condition for 1st, 3rd, 5th, 7th, and 10th
days, respectively. While the amounts of pulmonary cytokines
(IL-1, IL-4, IL-6, TNF-α, TGF-β), pIgR (SC), IgA and SIgA
were determined. The aim of the this work was to gain a better
understanding of the hyperoxia effects on the immunological
function of the lung.
Material and Methods
Animal Model
Animal model was built as described previously [13]. Briefly,
within 12 hours of birth, all pups were randomly divided into
air-inhaling group (group that was exposed to room air,
FiO2=0.21, N=68) and hyperoxia group (group that was
exposed to 90~95 % O2, FiO2=0.9~0.95, N=203). In the
hyperoxia group, oxygen was continuously delivered into
sealed environmental chambers to achieve a constant concen-
tration of 90–95 % oxygen, as confirmed by an oxygen mon-
itor (OM-25ME,MAXTEC, American) daily. The air-inhaling
groupwas exposed to similar environmental conditions, except
they inhaled room air. Oxygen and room air were filtered
through natrolite to keep the CO2 concentration below 0.5 %
(as confirmed using a DapexGas Monitor, American). To
equalize the effect of nursing on the pups’ development, the
nursing mothers were switched every 24 h among different
groups and to eliminate maternal effects between groups (from
the air-inhaling group to the hyperoxia group and vice versa).
Chambers were opened for 1 h daily to switch the nursing
mothers. Room temperature (25~27 °C), humidity (70 %~
80 %), and daily light–dark cycles were automatically con-
trolled. All animal husbandry, animal handling and procedures
were reviewed and approved to conform to the animal Ethics
Committee of China Medical University guidelines. At each
time point, 10 pups were sacrificed to gain Bronchoalveolar
Lavage (BAL) fluid and another 10 pups were sacrificed to
dissect their pulmonary tissues.
Tissue Preparation
The neonatal rats were sacrificed by an intraperitoeal injection
of pentobarbital sodium. To standardize analysis, the right lung
lower lobe was fixed in situ with 4 % paraformaldehyde in
phosphate-buffered saline (pH 7.4) and then was embedded in
paraffin. The rest of the right lung was harvested for pIgR
mRNA analysis. The left lung was harvested for protein
analysis.
Bronchoalveolar Lavage (BAL)
The sacrificed neonatal rats were placed in a supine posi-
tion. Ice-cold normal saline (NS) was gently instilled by
syringe until resistance was felt. After 1–2 min, the NS
was withdrawn and collected. Each animal was lavaged five
times. Lavage fluid was collected, centrifuged to remove
cells and debris. The supernatants were stored at −80 °C.
Enzyme-linked Immunosorbent Assay (ELISA)
ELISA kits was employed to measure the concentrations of
TNF-α (KeyGEN, Nanjing, China), IL-1, IL-4, IL-6 and
TGF-β (RB, American), IgA and SIgA (IBL, Hamburg,
Germany), following the manufacturer’s instructions. The
absorbance of each solution was determined at a wavelength
of 450 nm. Assay sensitivities as well as intra- and inter-
assay coefficients were determined for all of the biomarkers
tested. They are as follows: 8 ng/L, 9 % and 15 % for IL-1
and IL-6; 5 ng/L and 9 % and 15 % for IL-4; 10 ng/L and
9 % and 15 % for TGF-β; 5 ng/ml and 9.5 % and 9.5 % for
TNF-α; 30 ng/ml and 9 % and 11 % for IgA; 3.0 ng/ml and
8 % and 10 % for SIgA, respectively.
Immunohistochemistry for the Detection of Pulmonary
Tissue IgA and SC
Paraffin-embedded sections of the pulmonary tissues were
deparaffinized, rehydrated, and incubated with rabbit anti-
rat SC (Bethyl, American) and goat anti-rat IgA (Sigma,
American). The slides were rinsed three times with PBS
between incubations, and sections were counterstained with
hematoxylin. In the negative control, the primary antibody
was replaced with PBS. The median absorbance values of
IgA and SC were determined using the Image analysis
software (Shanghai, China) after scanning.
Protein determination The BCA Protein Assay Kit
(Beyotime, shanghai, China) was used to determine protein
concentration of pulmonary tissue according to the manu-
facturer’s instructions.
Western Blot for Analysis of pIgR Protein in Pulmonary
Tissues
Proteins extracted from pulmonary tissues were separated
using sodium dodecyl sulfate (SDS) polyacrylamide gel
electrophoresis and transferred to polyvinylidene fluoride
membranes. The membranes were blocked with Tris-buffer
containing 50 ng/L skim milk and probed with rabbit anti-
rat SC antibody (Bethyl, American) or β-actin (Sigma,
American) followed by a peroxidase-conjugated secondary
antibody. They were then incubated with an enhanced
chemiluminescent substrate and exposed to X-OMAT film
(Perkin Elmer, American). Images were scanned and densi-
tometry was analyzed for pIgR protein levels normalized to
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β-actin using the Tanon GIS-2020 software (Tanon, Shang-
hai, China).
Quantitative Real-time Polymerase Chain Reaction
of Pulmonary pIgR mRNA
Total RNAwas extracted from pulmonary tissue of neonatal
rats using an RNA Mini Kit from Takara (Takara Biotech-
nology Co., Dalian, China). The quality of extracted RNA
was determined by the number and size of the bands
obtained using agarose gel electrophoresis. cDNA was syn-
thesized using 100 ng RNA. The levels of individual RNA
transcripts were quantified using quantitative real-time po-
lymerase chain reaction (PCR). The primers for SC/pIgR
were as follows:
pIgR-F: 5′- CGATGGTGACTCTCGCTGGA -3′;
pIgR-R: 5′- TTGCACGGATAGTGGCAGGA -3′;
GAPDH-F: 5′-AATGGTGAAGGTCGGTGTG-3′;
GAPDH-R: 5′-TGAAGGGGTCGTTGATGG-3′.
The primers and fluorescent probes for pIgR and internal
reference (GAPDH) were purchased from Takara. The PCR
conditions were as follows: a preliminary cycle at 95 °C for
10 s, followed by 45 cycles at 95 °C for 5 s and at 60 °C for
20 s, followed by 1 min at 60 °C and 5 s at 95 °C. We also
confirmed that the efficiency of amplification for each target
gene (GAPDH) was 100 % in the exponential phase of PCR.
The mRNA levels were normalized to GADPH mRNA
according to the following formula: relative levels of pIgR
mRNA=(2-(CTpIgR-CT GAPDH))×100 %. Pulmonary mRNA
levels of the hyperoxia groups were compared with those of
air-inhaling group.
Statistical Analysis
For each experiment, at least 10 mice at different time point
were tested. Data on group differences were reported as the
means±SD. Significant differences between treatment
groups were determined using the t-test.
Results
The Pathological Changes of Lung Tissues
In the air-inhaling group (Fig. 1a), the lung mucosal epithe-
lium was simple columnar or cubical epithelium, and mu-
cosal epithelium was integrity, morphology was regulation.
In the hyperoxia group (Fig. 1b–f), the lung alveolar dilated
and breaked, and mucosal epithelium was integrity, and its
morphology was irregulation in the late period of hyperoxia
(red arrow in Fig. 1). The histological findings suggested a
decreased elasticity.
Analysis of Cytokines in BAL Fluid
Compared with those of the air-inhaling group, the
expression level of IL-1 remained relatvely invariant
on the first 5 days, and a mild increase was observed
on the 7th and 10th days. But this increase was not
significantly different (Fig. 2a). The expression level of
IL-4 was significantly elevated (through day 1 to 10)
and peaked on the 10th day (Fig. 2b). The expression
level of IL-6 were remarkably elevated on 5th and 7th
days, but not on the 1st, 3rd, and 10th days (Fig. 2c).
TNF-α levels increased on the 3rd, 5th, and 7th days
(Fig. 2e), while TGF-β stayed relatively constant at the
first 3 days, and increased significantly on the 5th, 7th,
and 10th days (Fig. 2d).
The Content of IgA and SIgA in BAL Fluid
In the air-inhaling group, IgA (Fig. 3a) and SIgA (Fig. 3b)
were increased gradually in a day-dependent manner. In the
hyperoxia group, IgA and SIgAwere significantly increased
compared with those of the air-inhaling group on the 3rd,
5th, and 7th days. On the 10th day, the IgA level quickly
decreased to a similar level with that of the air-inhaling
group, while the SIgA level droped notably lower than those
of the other groups in hyperoxia.
Pulmonary IgA and SC Staining
Immunochemistry staining of IgA in the cytoplasm of
airway epithelial cells was pale in the air-inhaling group
(Fig. 4a–e). In the hyperoxia group, IgA staining was
pale on the 1st (Fig. 4f) and 10th (Fig. 4j) days; was
yellow on the 3rd day (Fig. 4g); was brown on the 5th
day (Fig. 4h); and was dark brown on the 7th day
(Fig. 4i). As shown in Fig. 5a–e, in the air-inhaling
group, the staining of SC was yellow in the cytoplasma
and on the membranes of the airway epithelial cells. SC
staining of the airway epithelial cells from the hyperoxia
group were dark brown on the 3rd, 5th and 7th days and
light brown on the 10th day (Fig. 5f–j). The median
absorbance value showed that the level of pulmonary
IgA in the hyperoxia group was significantly increased
compared with those of the air-inhaling group on the 5th,
and 7th days (P<0.01). But on the 10th day, the level of
IgA in the hyperoxia group was close to that in the air-
inhaling group. The mean absorbance values of SC in the
hyperoxia group was significantly increased compared
with those in the air-inhaling group on the 3rd, 5th,
and 7th days (P<0.01). But on the 10th day, it was
remarkably decreased compared with those of 3rd, 5th,
and 7th days in the hyperoxia group (P<0.01; Fig. 6a
and b).
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pIgR Protein of Pulmonary Tissue Detected by Western Blot
Three subunits of pIgR protein (85KD, 92KD, 107KD)
were detected (Fig. 7a). In the air-inhaling group, the
85KD pIgR protein was increased in a day-dependent man-
ner, while the 92 KD pIgR protein remained at a lower level
until the 7th day when a sudden increase appeared. Densi-
tometry analysis (pIgR densitomety/β-actin densitomety)
showed that both the expression of the 85KD (Fig. 7b)
and 92KD (Fig. 7c) pIgR proteins in the hyperoxia group
were significantly increased on the 1st, 3rd, 5th and 7th
days. But it was significantly decreased on the 10th day
compared with those of the 3rd, 5th and 7th days in the
hyperoxia group (P<0.01).
pIgR mRNA of Pulmonary Tissues in Hyperoxia Neonatal
Rats
The mRNA expression of pulmonary pIgR in the hyperoxia
group on the 3rd, 5th and 7th days were 8.67±2.85, 8.46±
2.36, and 18.60±3.34, respectively. In the hyperoxia group,
the mRNA expression of pulmonary pIgR was significantly
a b c
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Fig. 1 The pathological
changes of pulmonary tissues.
(a) air group; (b) 1st day in
hyperoxia; (c) 3rd day in
hyperoxia; (d) 5th day in
hyperoxia; (e) 7th day in














































































































Fig. 2 The levels of cytokines
in BAL. The levels of cytokines
in BAL were compared and
analyzed on various neonatal
days. (a) IL-1; (b) IL-4; (c) IL-
6; (d) TGF-β; (e) TNF-α; *P<
0.01 compared with the air-
inhaling group, IL-4, IL-6 and
TGF-β of hyperoxia group
were significantly elevated;
TNF-α of hyperoxia group was
significantly increased on the
3rd, 5th, and 7th days (n=10 in
each time point)
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increased on the 3rd, 5th and 7th days compared with that of
the air-inhaling group (3rd day 3.14±0.82; 5th day 4.59
±2.32; 7th day 4.27 ±0.46; P<0.01). However, on the 10th
day, the mRNA expression of pulmonary pIgR (4.29±3.22)
was notably lower than those of the other groups in
hyperoxia and that of the 10th day in the air-inhaling group
(6.82±7.84) (P<0.01; Fig. 8).
Discussion
Hyperoxia is an indispensable therapeutic measure in
intensive clinical neonatal disease. But it is also a major
factor of lung injury. Early exposure to hyperoxia re-
sults in progressive lung disease in premature infants
[12]. This lung disease is associated with an initiation
phase of injury, followed by an inflammatory phase and
a destructive phase and ends at a final fibrotic stage
[15]. In general, 6 to 48 h of hyperoxia is sufficient to
cause marked pulmonary inflammation in infant rats
[16]. Hyperoxia induces lung injury characterized by
the development of pulmonary edema and inflammation
[17]. The acute lung injury caused by hyperoxia is
characterized by severe endothelial damage, alveolar
epithelial injury, and increased pulmonary permeability
[18]. We guessed that the mechanisms that caused the
pathological change may be associated with changes of
pulmonary local immune function.
IgA is synthesized and assembled to form pIgA by
pulmonary subepithelial or glandular interstitial plasma
cells. SIgA is formed by the association of pIgA and
pIgR (SC), which is produced by the ciliated cells of
bronchial epithelialium and the serous cells of submu-
cosal glands. This association with pIgR (SC) has been
shown to protect SIgA from proteolytic degradation. In
this study, IgA and SIgA in BAL fluid were gradually
increased following neonatal rat development in the air-
inhaling group. In the hyperoxia group, IgA and SIgA
in BAL fluid were significantly increased on the 3rd,
5th, and 7th days, however, were quickly decreased on
the 10th day. The immunohistochemical results were
similar with those of BAL fluid. This proved that the
increased IgA in BAL was not local transcytosis of IgA
but was IgA produced by pulmonary subepithelial or
glandular interstitial plasma cells. Since one molecule
of the pIgR is consumed for every molecule of SIgA
released into luminal secretions, the increased synthesis













































Fig. 3 The levels of IgA and SIgA in BAL. (a) IgA; (b) SIgA. The
content of IgA and SIgA in BAL were compared and analyzed on each
neonatal day. *P<0.01 compared with the air-inhaling group, IgA and
SIgA of hyperoxia group were significantly increased on the 3rd, 5th,
and 7th days; **P<0.01 IgA and SIgAwere significantly decreased on
the 10th compared with those of the 3rd, 5th, and 7th days in hyperoxia
group(n=10 in each time point)
a b c d e
f g h i j
Fig. 4 IgA staining of pulmonary tissues. a–e, Pulmonary IgA
staining was pale in the air-inhaling group (n=10 in each time point).
The staining results indicated that in the air-inhaling group, pulmonary
IgA in the neonatal rats was much less. f–j, Pulmonary IgA staining in
the hyperoxia group (n=10 in each time point). IgA staining was pale
on the 1st (f) and 10th (j) days; was yellow on the 3rd day (g); was
brown on the 5th day (h); and was dark brown on the 7th day (i) (see
arrows). Magnification bars=50 μm(n=10 in each time point)
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[19]. It is reported that the initiation phase of hyperoxia
represented a sensitively balanced activation of damag-
ing and protective systems in lung tissue [20]. SIgA can
control mucosal inflammatory responses and therefore
protect host tissues from damage [21]. Thus we specu-
lated that in the early period of neonatal rats exposed to
hyperoxia, large amounts of IgA and SIgA were pro-
duced to defend against acute pulmonary injury.
Polosukhin et al. reported that SIgA levels in BAL from
patients with chronic obstructive pulmonary disease
were reduced [22]. He deemed that bronchial epithelial
remodeling led to abnormalities in SIgA trafficking to
the airway that impaired local host defenses [22]. An-
other report also stated that SIgA in bronchial secretions
was decreased in cystic fibrosis [23]. So we considered
the decrease of SIgA at the 10th day of hyperoxia as a
pulmonary epithelial impairment.
pIgR is synthesized as a 90–100 KD precursor pro-
tein that matures to 100–120 KD [1]. Human pIgR is
expressed as two different molecular weight forms, 92
and 107KD [24]. The 107KD pIgR is a fully
glycosylated Golgi form of the protein, but the 92KD
pIgR is immature form. SC, which is the extracellular
component of the pIgR, is a 80-85KD protein [25, 26].
It has been reported that mouse pIgR is a 120KD
protein and SC is a 94KD protein [23]. In the hyperoxia
group the 85KD and 92KD SC protein were dramati-
cally increased on the 3rd, 5th and 7th days and were
significantly attenuated on the 10th day. This could
demonstrate that pIgR was involed in transcytosis of
IgA and lysis SC induced by hyperoxia. 107KD pIgR
was gradually increased in a day-dependent manner in
air-inhaling group, but in the hyperoxia group its ex-
pression was undetectable with Western blot. This could
reflect the fact that there was less matured pIgR and a
large amount of pIgR involving in the synthesis of
SIgA in hyperoxia group. Furthermore, the mRNA ex-
pression of pIgR were up-regulated in a day-dependent
manner in the early period but were decreased in the
late period of hyperoxia. This suggests that hyperoxia
may result in the destruction and/or damage of respira-
tory epithelium. In early stage of damage, a large
amount of pIgR was secreted to form SIgA to protect
the lung from acute injury. However, in late stage of
damage, the respiratory epithelium was destroyed so
that the secretion of pIgR was decreased.
The key regulators of IgA and pIgR expression are
cytokines. In the present study IL-4 was significantly
Fig. 5 SC staining of pulmonary tissues. a–e, Pulmonary SC staining
was brown in the air-inhaling group(n=10 in each time point). The
staining results indicated that pulmonary SC in neonatal rats was
secreted when they were born. f–j, Pulmonary SC staining was dark
brown in the hyperoxia group(n=10 in each time point). Magnification


























































Fig. 6 The median absorbance values of SC and IgA. Compared with
the air-inhaling group, the levels of IgA (on the 5th, and 7th days) and
SC(on the 3rd, 5th, and 7th days) in the hyperoxia group were signif-
icantly increased (P<0.01). However, on the 10th day, in the hyperoxia
group the level of IgA was close to that of the air-inhaling group and
the level of SC was remarkbly decreased compared with those of 3rd,
5th, and 7th days (P<0.01); Data were reported as the means±SD (t-
test) (n=10 in each time point)
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elevated in a day-dependent manner, though previous
studies had demonstrated that IL-4 was not altered in
hyperoxic lung injury in neonatal mice models [27].
Waheed et al. reportd that hyperoxia increased TGF in
a neonatal rabbit hyperoxia-fibrosis model [28]. Our
results showed that TGF-β stayed relatively constant at
the first 3 days, but increased significantly in the late
period of hyperoxia. So we speculated that TGF-β
might be associated with pulmonary tissue impairment
in late period of neonatal rats exposed to hyperoxia.
Pro-inflammatory cytokines-TNF-α and IL-6 were in-
creased in the hyperoxia group. This was in agreement
with previous report [29]. Some authors thought that
hyperoxia inducing pulmonary inflammation was medi-
ated by TNF-α [19]. Therefore we concluded that the
increased TNF-α would mediate the inflammatory re-
sponse and lead to impairment of the lung [27]. Fur-
thermore, IL-6 is a central regulator in the inflammatory. It is
both a pro-inflammatory and an anti-inflammatory molecule.
Its anti-inflammatory effect showed that it confered significant
protection from hyperoxic acute lung injury. This protective
response appeared to result from the ability of the IL-6 to
inhibit hyperoxia-induced cell death [30, 31]. These rapid
cytokine response in the setting of hyperoxic injury might
play an important role in the adaptation of neonatal lungs to
toxicity from prolonged oxygen exposure [27]. Although IL-1
was a multifunctional cytokine involved in immune re-
sponses, inflammation and hematopoiesis, in this study there
was no significant change in the hyperoxia group.
The increased airway IgA after injury is thought to be a
protective response and has been associated with increases in
airway TNF-α and IL-6 [32]. IL-6 is an inducer of plasma cell
development and also influences IL-4 production. IL-4 is
known to upregulate IgA production and transport. TGF-β
has been shown to be a crucial cytokine for IgA switching [1].
Thus, during the early period, the increase of TGF-β, TNF-α,
IL-6 and IL-4 in the hyperoxia group might be factors in the
pulmonary IgA increase. The expression of pIgR appear to be
upregulated by different cytokines, such as TNF-α [25, 26],
IL-4 [33, 34], IL-1 [35] and TGF-β [36]. As mentioned
before, cytokines (IL-4, IL-6, TNF-α and TGF-β) were
A air-inhaling hyperoxia

































































Fig. 7 Effect of hyperoxia on
pIgR expression of pulmonary
tissues. a: specific bands for
pIgR. b: densitometric analysis
of 85KD (n=10 in each time
point). c: densitometric analysis
of 92KD (n=10 in each time
point). Both the relative
expression rates of the 85KD
and 92KD pIgR proteins in the
hyperoxia group were
significantly increased on the
1st, 3rd, 5th and 7th days(*P<
0.01) but significantly
decreased on the 10th day
compared with those of the air-
inhaling group (**P<0.01).β-
actin was served as an internal
control. Densitometric
measurements were used for

































Fig. 8 Relative content of the pulmonary pIgR mRNA. Relative
content of pulmonary pIgR mRNA on the 3rd, 5th and 7th days in
the hyperoxia group were significantly increased compared with those
of the air-inhaling group (*P<0.01). On the 10th day, the relative
content of pulmonary pIgR mRNA was notably decreased compared
with those of the 3rd, 5th and 7th days in the hyperoxia group(**P<
0.01) (Data were reported as the means ± SD, P<0.01) (n=10 in each
time point)
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significantly increased in the hyperoxia group. So we pro-
posed that the increased expression of pIgR was probably
related to the effect on epithelia of the higher production of
these cytokines in the hyperoxia group.
Conclusions
Taken together, in the early period of hyperoxia, large amounts
of IgA, SC and SIgA in the lungs of neonatal rats were
produced to defend against acute pulmonary injury, but in the
late period of hyperoxia, the decrease of IgA, SC and SIgA
might lead to attenuation of pulmonary immunity. In hyperoxia
condition, the elevated expression of cytokines might contrib-
ute to the expression of IgA and SC.
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